Copyright
©The Author(s) 2025.
World J Diabetes. Jul 15, 2025; 16(7): 107335
Published online Jul 15, 2025. doi: 10.4239/wjd.v16.i7.107335
Published online Jul 15, 2025. doi: 10.4239/wjd.v16.i7.107335
| Ref. | Random sequence generation | Allocation concealment | Blinding of participants | Blinding of outcome assessment | Incomplete outcome data addressed | Selective reporting | Other sources of bias |
| Inagaki et al[22] | Unclear | Low risk | Low risk | Low risk | Low risk | Low risk | Low risk |
| Jabbour et al[41] | Unclear | Unclear | Low risk | Low risk | Low risk | Low risk | Low risk |
| Kaku et al[23] | Unclear | Low risk | Low risk | Low risk | Low risk | Low risk | Low risk |
| Seino et al[42] | Unclear | Low risk | Low risk | Low risk | Low risk | Low risk | Low risk |
| Seino et al[24] | Unclear | Low risk | Low risk | Low risk | Low risk | Low risk | Low risk |
| Seino et al[25] | Unclear | Low risk | Low risk | Low risk | Low risk | Low risk | Low risk |
| Kashiwagi et al[26] | Unclear | Low risk | Low risk | Low risk | Low risk | Low risk | Low risk |
| Kashiwagi et al[27] | Unclear | Low risk | Low risk | Low risk | Low risk | Low risk | Low risk |
| Kashiwagi et al[28] | Unclear | Unclear | Low risk | Low risk | Low risk | Low risk | Low risk |
| Kashiwagi et al[29] | Unclear | Unclear | Low risk | Low risk | Low risk | Low risk | Low risk |
| Liao et al[30] | Low risk | Unclear | Low risk | Low risk | Low risk | Low risk | Low risk |
| Wang et al[43] | Unclear | Unclear | Low risk | Low risk | Low risk | Low risk | Low risk |
| Terra et al[31] | Low risk | Unclear | Low risk | Low risk | Low risk | Low risk | Low risk |
| Dagogo-Jack et al[32] | Low risk | Unclear | Low risk | Low risk | Low risk | Low risk | Low risk |
| Eriksson et al[33] | Low risk | Low risk | Low risk | Low risk | Low risk | Low risk | Low risk |
| Han et al[34] | Low risk | Unclear | Low risk | Low risk | Low risk | Low risk | Low risk |
| Hattori[35] | Unclear | Unclear | Low risk | High risk | Low risk | Low risk | Low risk |
| Brown et al[36] | Unclear | Unclear | Low risk | Low risk | Low risk | Low risk | Low risk |
| Chehrehgosha et al[44] | Low risk | Low risk | Low risk | Low risk | Low risk | Low risk | Low risk |
| Phrueksotsai et al[45] | Low risk | Unclear | Low risk | Low risk | Low risk | Low risk | Low risk |
| Cheng et al[37] | Low risk | Low risk | Low risk | Low risk | Low risk | Low risk | Low risk |
| Gohari et al[38] | Low risk | Low risk | Low risk | Low risk | Low risk | Low risk | Low risk |
| Kwak et al[39] | Unclear | Unclear | Low risk | Low risk | Low risk | Low risk | Low risk |
| Yang et al[40] | Unclear | Unclear | Low risk | Low risk | Low risk | Low risk | Low risk |
- Citation: Chai SY, Zhang RY, Ning ZY, Zheng YM, Swapnil R, Ji LN. Sodium-glucose co-transporter 2 inhibitors improve insulin resistance and β-cell function in type 2 diabetes: A meta-analysis. World J Diabetes 2025; 16(7): 107335
- URL: https://www.wjgnet.com/1948-9358/full/v16/i7/107335.htm
- DOI: https://dx.doi.org/10.4239/wjd.v16.i7.107335